← Leaderboards
Susmit Suvas
Oakland University
$7,410,955
Attributed
$7,410,955
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,410,955 · 5
By mechanism
R01$7,015,393 · 4
R21$395,562 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessInflammationInflammatoryLesionCorneaReportingInfectionSeveritiesResponseChronicPathogenesisCellsHerpesvirus 1Mouse ModelStainsImmuneMediatingRecurrenceKeratitisNeutrophilExperimental StudyViral Load ResultBlood VesselsNovel Strategies
Grant awards (22)
CXCR4: A potential therapeutic target in HSK$385,000
R01 · FY2025 · EY · contact PI
CXCR4: A potential therapeutic target in HSK$385,000
R01 · FY2024 · EY · contact PI
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.$385,000
R01 · FY2024 · EY · contact PI
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis$422,542
R01 · FY2023 · EY · contact PI
CXCR4: A potential therapeutic target in HSK$385,000
R01 · FY2023 · EY · contact PI
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.$374,603
R01 · FY2023 · EY · contact PI
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis$409,864
R01 · FY2022 · EY · contact PI
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.$363,365
R01 · FY2022 · EY · contact PI
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis$409,865
R01 · FY2021 · EY · contact PI
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.$363,364
R01 · FY2021 · EY · contact PI
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis$422,542
R01 · FY2020 · EY · contact PI
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.$377,440
R01 · FY2020 · EY · contact PI
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis$437,542
R01 · FY2019 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$385,000
R01 · FY2017 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$383,535
R01 · FY2016 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$40,000
R01 · FY2016 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$374,133
R01 · FY2015 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$196,858
R01 · FY2014 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$156,381
R01 · FY2014 · EY · contact PI
Corneal neuropeptides and herpetic stromal keratitis$358,359
R01 · FY2013 · EY · contact PI
Role of corneal neuropeptides in the pathogenesis of herpetic stromal keratitis$177,600
R21 · FY2011 · EY · contact PI
Role of corneal neuropeptides in the pathogenesis of herpetic stromal keratitis$217,962
R21 · FY2010 · EY · contact PI